IRMD
IRADIMED CORP
NASDAQ · Healthcare · Medical - Devices · US
$87.65
−0.70%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$88.76
From 52W high−16.64%
Volume79226.00
Market cap$1.12B
P/E (TTM)48.2x
P/S (TTM)13.0x
Div yield1.45%
Key dataOct 19, 2026
Open
$88.76
From 52W high
−16.64%
Volume
79226.00
Market cap
$1.12B
ValuationView details →
P/E (Fwd)
35.4x
EV/EBITDA
34.4x
P/E (TTM)
48.2x
RSI (14)
54.9
MomentumView details →
1D Return
−0.70%
YTD Return
−9.60%
SummaryUpdated Jun 1, 2026
IRadimed Corporation (NYSE:IRMD) is a specialized medical device manufacturer founded in 1992 and headquartered in Winter Springs, Florida. The company went public in July 2014 and has established itself as a leading provider of magnetic resonance imaging (MRI) compatible medical devices. IRadimed operates in the niche but critical market of developing equipment that can safely function within the powerful magnetic fields of MRI machines, serving hospitals, acute care facilities, and outpatient imaging centers across the United States and internationally.
Similar companies
Latest newsMore news →
iRadimed began general-release production of its new 3870 MRI IV pump system in the second quarter of 2026.80d agoIRADIMED CORPORATION reported second quarter 2026 revenue of $20.5 million, up 0.5% year-over-year, with GAAP diluted EPS of $0.41 and non-GAAP diluted EPS of $0.46.80d agoIRADIMED CORPORATION announced a regular quarterly cash dividend of $0.20 per share.80d ago